"New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care and blood disorder services. With six convenient locations in Albany, Amsterdam, Clifton Park in Saratoga County, Hudson, and Troy, our team of 35 physicians and more than 350 cancer care specialists see more than 100,000 cancer visits a year."

During the past decade, Riverview Cancer Care Medical Associates, PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverview Cancer Care Medical Associates, PC" #1 sponsor was "NSABP Foundation Inc" with 4 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverview Cancer Care Medical Associates, PC" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Riverview Cancer Care Medical Associates, PC" are "Breast Cancer" (4 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "Extensive Stage Small Cell Lung Carcinoma" (1 trials), "Gastrinoma" (1 trials) and "Glucagonoma" (1 trials). Many other conditions were trialed in "Riverview Cancer Care Medical Associates, PC" in a lesser frequency.

Most popular intervention types in "Riverview Cancer Care Medical Associates, PC" are "Drug" (11 trials), "Other" (4 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Placebo" (2 trials), "cyclophosphamide" (2 trials), "Axitinib (AG-013736)" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverview Cancer Care Medical Associates, PC" are 7 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Riverview Cancer Care Medical Associates, PC". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Riverview Cancer Care Medical Associates, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Riverview Cancer Care Medical Associates, PC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".